human clinical trial Applications
-
Medical cannabis solutions for regulatory pathway sector
Health Canada recently released “Proposed Regulations Amending the Cannabis Regulations (new classes of cannabis) and Proposed Order Amending Schedules 3 and 4 to the Cannabis Act”. These proposed changes introduce three new classes of cannabis products: edibles, concentrates and topicals. The introduction of these new classes may present an opportunity for the Company to bring combination products to the market as an adult-use edible cannabis product. It is proposed that only approved food ingredients ...
By CanaQuest Medical Corp. based in Mississauga, ONTARIO (CANADA).
-
Microbiome Therapeutics for Clinical Trials
Finch’s lead candidate, CP101, is in late-stage clinical development for the ...
By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).
-
TP508 & Covid-19
There remains a critical need for a therapeutic to be used in combination with antivirals to prevent COVID-19 progression and reduce post-recovery complications. SARS-CoV-2-induces a “cytokine storm” in the lungs and causes vascular damage throughout the body. Viral infection and cytokine-induced vascular damage initiate intravascular coagulation that leads to multiple organ failure and post-recovery damage to the brain and heart. Thus, COVID-19 is now recognized as an endothelial dysfunction-related ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
-
Human biology solutions for ADME-Tox sector
30% of drugs fail during human clinical trials due to adverse reactions despite promising ...
By Emulate based in Boston, MASSACHUSETTS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you